Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar-Apr;67(2):205.
doi: 10.4103/ijd.ijd_543_21.

Clinico-Epidemiologic Attributes of 515 Persons Living With Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome on Antiretroviral Therapy: A Cross-Sectional Study from a Tertiary Care Centre of North India

Vikram K Mahajan  1 , Mrinal Gupta  1 , Rajni Sharma  1 , T N Shiny  1 , Sarita Gupta  1 , Rattan S Rashpa  1
Affiliations

Clinico-Epidemiologic Attributes of 515 Persons Living With Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome on Antiretroviral Therapy: A Cross-Sectional Study from a Tertiary Care Centre of North India

Vikram K Mahajan et al. Indian J Dermatol. 2022 Mar-Apr.

Abstract

Objectives: To study the clinico-epidemiologic attributes of persons living with HIV/AIDS on highly active antiretroviral therapy (HAART).

Methods: Clinico-epidemiological details, CD4 counts, previous illness and mucocutaneous diseases were studied in 515 persons living with HIV/AIDS on HAART.

Results: The study comprised 250 (48.5%) males and 265 (51.5%) females aged between 10 and 79 (mean 38.9) years. The 196 (38%) males were drivers, staying-alone laborers/self-employed, and 253 (49.1%) females were homemakers. All were on HAART for one month to 9 years. Heterosexual transmission was noted in 478 (92.8%) individuals. The 274 (53.5%) individuals had 200-350 CD4 cells/mm3 counts, whereas it was <200 cells/mm3 in 88 (17.2%) individuals. Candidiasis (in 48), dermatophytoses (n = 23), herpes labialis (n = 13), herpes zoster (n = 12), seborrheic dermatitis (n = 29), generalized pruritus (n = 22), and xerosis in 20 individuals were the most common dermatoses. Most dermatoses occurred with 200-350 CD4 cells/mm3. Adverse drug reactions from antiretroviral therapy (ART) and concurrent therapies also occurred.

Conclusions: Although most of our patients had mild HIV-associated dermatoses while on HAART, adverse drug reactions from HAART or concurrent therapies themselves remain a potential risk. Nevertheless, knowledge of these aspects will help planning for comprehensive health care envisaged in the National AIDS Control Program phase IV.

Keywords: Acquired immunodeficiency syndrome; CD4 counts; heterosexual transmission; highly active antiretroviral therapy; human immunodeficiency virus; mucocutaneous manifestations.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Severe hyperplastic oral candidiasis in a patient with CD4 counts of 72 cells/mm3
Figure 2
Figure 2
Multiple common warts in a patient having CD4 counts of 154 cells/mm3
Figure 3
Figure 3
Disseminated histoplasmosis in a patient having CD4 counts of 53 cells/mm3
Figure 4
Figure 4
Nevirapine hypersensitivity syndrome (Stevens-Johnson syndrome) in a patient with CD4 counts of 168 cells/mm3
Figure 5
Figure 5
Trichomegaly of eyelashes
Figure 6
Figure 6
Palmoplantar keratoderma possibly from retention hyperkeratosis
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. National AIDS Control Organization. India HIV estimations 2015. Technical Report. Department of AIDS Control. Ministry of Health and Family Welfare, New Delhi, India. [Last accessed on 2020 Dec 25]. Available from: http://www.naco.gov.in .
    1. National AIDS Control Organization. State epidemiological fact sheets, Vol. III, Northern, Central & Eastern Region, 2017. Department of AIDS Control. Ministry of Health and Family Welfare, New Delhi, India. [Last accessed on 2020 Dec 25]. Available from: http://www.naco.gov.in .
    1. Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol. 2004;70:82–6. - PubMed
    1. Sud N, Shanker V, Sharma A, Sharma NL, Gupta M. Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts. Int J STD AIDS. 2009;20:771–4. - PubMed
    1. Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Indian J Sex Transm Dis. 2013;34:19–24. - PMC - PubMed